JPRN-UMIN000016165已完成2 期
An exploratory study to evaluate molecular predictive and/or prognostic factors of benefit from a randomized, phase III trial of sequential capecitabine/5FU plus bevacizumab (Cape/5FU-Bmab) to capecitabine/5FU plus oxaliplatin plus bevacizumab (CapeOX/mFOLOFX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer. - C-Prime Study
Department of clinical oncology, Kawasaki Medical School0 个研究点目标入组 132 人开始时间: 2015年1月9日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 132
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
iver protective drug action of homoeopathic preparation of Myrica cerifera 3C on Non alcoholic fatty liver diseaseCTRI/2022/02/040009Dr Raja Manoharan
已完成
不适用
The exploratory study for the drug-predictive markers of TS-1 in metastatic or recurrent breast cancer; Translational biomarker study of SELECT BC trialJPRN-UMIN000014245SELECT BC executive committee140
进行中（未招募）
不适用
BIOEMBRACE-1CTRI/2019/03/018331Tata memorial Centre
尚未招募
不适用
The exploratory study to determine predictive biomarkers of response to immune checkpoint inhibitors for patients with metastatic urological cancersJPRN-UMIN000038617Department of Urology, Graduate School of Medicine, Yamaguchi University190
招募中
不适用
Evaluation of preclinical predictors for the genesis of out-of-hospital resuscitatioI46.9Cardiac arrest, unspecifiedDRKS00031605niversitätsklinikum Freiburg1,100